Author Information
Kwangmeyung Kim is affiliated with the Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), located at Hwarangno 14-gil 5, Seongbuk-gu, Seoul, Republic of Korea. He is also associated with the KU-KIST Graduate School of Converging Science and Technology at Korea University, situated at Anam-no 145, Seongbuk-gu, Seoul, Republic of Korea.Research Contributions
Kwangmeyung Kim has made significant contributions to the field of nanotechnology, particularly in the area of cancer therapy. His recent works in 2022 include research on light-activated prodrug nanoparticles for combinational photo-chemotherapy of pancreatic cancer, tumor-activated carrier-free prodrug nanoparticles for targeted cancer immunotherapy, and anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy. Additionally, his studies encompass the combination of conventional nanoparticle-mediated photothermal therapy with cancer immunotherapy, and the development of nanoparticles for brain imaging and treatment. His work is pivotal in advancing drug delivery systems and enhancing the efficacy of cancer treatments.Aliases
Kwangmeyung Kim may also be known by the names Kwang Meyong Kim, Kwang-jae Kim, and Kwang-kyu Kim.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
25,699 |
| H-index |
87 |
| Paper Count |
408 |
